Skip to main content
SpringerLink
Log in

Literatur

  • Chapter
Book cover Nizatidin

  • 12 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Anonymus (1984) Nizatidine. Drug Fut 9(9): 655

    Google Scholar 

  • Anonymus (1985) Nizatidine Axid. Drug Fut 9(9): 787

    Google Scholar 

  • Anonymus (1986) Nizatidine Axid. Drug Fut 11(9): 807

    Google Scholar 

  • Anonymus (1987) Nizatidine Axid. Drug Fut 12(9): 913

    Google Scholar 

  • Anonymus (1988) Nizatidine. Drug Fut 13(9): 897

    Google Scholar 

  • Aronoff G, Sloan R, Bopp R, Walters J, Bergstrom R, Callaghan J (1986) Nizatidine Kinetics in Patients with Renal Insufficiency. Clin Pharmacol Ther 39:178

    Google Scholar 

  • Aronoff G (1986a) Nizatidine in Subjects with or without Chronic Renal Failure. Lilly Research Labs. — Clinical Dokumentation Protocol 28 (unveröffentlichte Daten)

    Google Scholar 

  • Arthur BH (1981) The Acute Oral Toxicity of Compound LY139037 in the Mouse. Lilly Research Labs. — Toxicology Report Nr. 1 (unveröffentlichte Daten)

    Google Scholar 

  • Arthur BH (1981 a) The Acute Oral Toxicity of Nizatidine in the Fischer 344 Rat. Lilly Research Labs. — Toxicology Report Nr.2 (unveröffentlichte Daten)

    Google Scholar 

  • Arthur BH (1981b) The Acute Intraveneous Toxicity of Nizatidine in the Mouse. Lilly Research Labs. — Toxicology Report Nr.3 (unveröffentlichte Daten)

    Google Scholar 

  • Arthur BH (1981 c) The Acute Intraveneous Toxicity of Nizatidine in the Rat. Lilly Research Labs. — Toxicology Report Nr.4 (unveröffentlichte Daten)

    Google Scholar 

  • Arvela P, Pasanen P, Pelkanen O (1986) Effect of Induction on the Inhibitor of Drug Metabolism by Histamine H2-Receptor Antagonists. Naunyn Schmiedebergs Arch Pharmacol 332 (Suppl): 38

    Google Scholar 

  • Axon ATR (1986) Potential Hazards of Hypochlorhydria in the Treatment of Peptic Ulcer. Scand J Gastroenterol 21 (Suppl 122): 17

    Google Scholar 

  • Bergstrom RE (1987) The Clinical Pharmacology of Nizatidine. European Nizatidine Symposium, Brussels

    Google Scholar 

  • Bergstrom RE, Golichowski A, Obermeyer BD (1987 a) Breast milk Study. Lilly Research Labs. — IND Protocol Nr. B5Q-LC-NABE (unveröffentlichte Daten)

    Google Scholar 

  • Betton GR, Salmon GK (1984) Pathology of the Forestomach in Rats Treated for One Year with a New Histamine H2-Receptor Antagonist, SK 93479 Trihy-drochloride. Scand J Gastroenterol 19 (Suppl 101): 103

    CAS  Google Scholar 

  • Bewsey BJ (1983) The Effect of Nizatidine on the Induction of Forward Mutation at the Thymidine Kinase Locus of L5178Y Mouse Lymphoma Cells. Lilly Research Labs. — Toxicology Report Nr.27 (unveröffentlichte Daten)

    Google Scholar 

  • Black JW, Duncan WA, Durant CJ, Ganellin CR, Parsons EM (1972) Definition and Antagonism of Histamine H2-Receptors. Nature 236: 385

    CAS  PubMed  Google Scholar 

  • Bovero E, Poletti M, Boero A et al. (1987) Nizatidine in the Short-Term Treatment of Duodenal Ulcer — An Italian Multicenter Study. Hepatogastroenterology 34: 269

    CAS  PubMed  Google Scholar 

  • Bridge TL, Newman KS (1981) A 14-Day Acute Toxicity Study of Nizatidine (LY139037) Administered by Nasogastric Gavage to Rhesus Monkeys. Lilly Research Labs. — Toxicology Report Nr.26 (unveröffentlichte Daten)

    Google Scholar 

  • Brittain RT, Jack D, Price BJ (1981) Recent Developments in Histamin H2-Antagonists. Trends Pharmacol Sei 2: 310

    CAS  Google Scholar 

  • Broden R, Canuine A, Heel R (1982) Ranitidine: A Review of its Pharmacology and Therapeutic Use in Peptic Ulcer Disease and Other Allied Diseases. Drugs 24: 267

    Google Scholar 

  • Byrd RA (1984) A Teratology Study of Nizatidine Administered Orally to Wistar Rats. Lilly Research Labs. — Toxikology Report Nr.29 (unveröffentlichte Daten)

    Google Scholar 

  • Callaghan J (1983) Oral Administration of Nizatidine to Normal Male Volunteers l.Dose Ranging Study. Lilly Research Labs. — Clinical Dokumentation Protocol 3 (unveröffentlichte Daten)

    Google Scholar 

  • Callaghan J (1983 a) Multiple Dose Safety Study an Gastric Acid Suppression of Oral LY139037. Lilly Research Labs. — Clinical Dokumentation Protocol 4 (Unveröffentlichte Daten)

    Google Scholar 

  • Callaghan J, Bergstrom R, Obermeyer B, King E, Offen W (1985) Intravenous Nizatidine Kinetics and Acid Suppression. Clin Pharmacol Ther 37(2): 162

    CAS  PubMed  Google Scholar 

  • Callaghan J, Bergstrom R, Knadler M, Rubin A (1986) Nizatidine Disposition in Elderly Subjects. Clin Pharmacol Ther 39(2): 185

    Google Scholar 

  • Callaghan J (1986 a) The Interactions of H2-Blockers with Lidocaine and Indocyanine Green. Lilly Research Labs. — Clinical Dokumentation Protocol 27 (unveröffentlichte Daten)

    Google Scholar 

  • Callaghan J (1986 b) The Disposition of 14C-Nizatidine in Man. Lilly Research Labs. — Clinical Dokumentation Protocol 22 (unveröffentlichte Daten)

    Google Scholar 

  • Callaghan J, Bergstrom R, Rubin A et al. (1987) A Pharmacokinetic Profile of Nizatidine in Man. Scand J Gastroenterol 22 (Suppl 136): 9

    Google Scholar 

  • Callaghan J, Rubin A, Knadler M, Bergstrom R (1987 a) Nizatidine, an H2Receptor Antagonist: Disposition and Safety in the Elderly. J Clin Pharmacol 27(8): 618

    CAS  PubMed  Google Scholar 

  • Callaghan J (1987b) Nizatidine: Effects on Aspirin-induced Gastrointestinal Red Blood Cell Loss. Gastroenterology 92(5): 1336

    Google Scholar 

  • Callaghan J (1987c) Nizatidine: Effects on Aspirin-induced Gastrointestinal Red Blood Cell Loss. Pharmacologist 23(3): 590

    Google Scholar 

  • Cerulli M, Cloud M, Offen W, Chernish S, Matsumoto C (1987) Nizatidine as Maintenance Therapy of Duodenal Ulcer Disease in Remission. Scand J Gastroenterol 22 (Suppl 136): 79

    Google Scholar 

  • Cloud M, Matsumoto C, Offen W (1986) Two Nighttime Doses of Nizatidine Compared with Placebo in the Treatment of Acute Duodenal Ulcer. Am J Gastroenterol 81(9): 867

    Google Scholar 

  • Cloud M, Offen W, Matsumoto C (1986 a) Nizatidine Compared with Placebo in the Prevention of Recurrent Duodenal Ulcer. Am J Gastroenterol 81(9): 866

    Google Scholar 

  • Cloud M, Matsumoto C, Offen W (1986 b) Three Doses of Nizatidine Compared with Placebo in Treatment of Acute Duodenal Ulcer. Dig Dis Sei 31 (10 Suppl): 161

    Google Scholar 

  • Cloud M (1987) Safety of Nizatidine in Clinical Trials Conducted in the USA and Europe. Scand J Gastroenterol 22 (Suppl 136): 29

    Google Scholar 

  • Cloud M (1987 a) Prevention of Recurrent Duodenal Ulcer Disease with Nizati-dine. Gastroenterology 92(5): 1348

    Google Scholar 

  • Cloud M (1987 b) Efficacy and safety of Nizatidine 150 mg twice daily in the treatment of duodenal ulcer disease. Gastroenterology 92 (5, Part 2): 1348

    Google Scholar 

  • Cunningham M, Male P-J, Griessen M, Striberni R, Loizeau E (1985) 24-Hour-H+-Activity, Nocturnal Acid and Pepsin Output on A New H2-Receptor Antagonist Nizatidine. Am J Gastroenterol 80(10): 839

    Google Scholar 

  • Dammann HG, Müller P, Simon B (1983) 24 Hour Intragastric Acidity and Single Nighttime Dose of Three H2-Blockers. Lancet 2:1078

    CAS  PubMed  Google Scholar 

  • Damman HG, Jacubasch T, Walter T, Müller P, Simon B (1984) Intragastrale 24-Stunden-H+-Aktivität unter H2-Rezeptor-Antagonisten. Therapiewoche 34/36: 5092

    Google Scholar 

  • Dammann HG, Gottlieb W, Walter T, Müller P, Simon B (1985) Nocturnal Administration of Five Histamine H2-Receptor Antagonists: A Single Blind Comparative Study. Gastroenterology 88:1359

    Google Scholar 

  • Dammann HG, Gottlieb W, Walter T et al. (1986) Nocturnal Acid Suppression with a New H2-Receptor Antagonist — Nizatidine. Hepatogastroenterology 33: 217

    CAS  PubMed  Google Scholar 

  • Dammann HG, Klotz U, Gottlieb W, Walter T (1986 a) Nizatidine (300 mg nocte) Does Not Interfere with Diazepam Pharmacokinetics. Dig Dis Sei 31 (10 Suppl): Abstract 1570

    Google Scholar 

  • Dammann HG, Walter T, Müller P, Simon B, Keohane P (1986 b) Nizatidine and Duodenal Ulcer Healing. Dig Dis Sci 31 (10 Suppl): Abstract 948

    Google Scholar 

  • Dammann HG, Gottlieb W, Walter T, Müller P, Simon B, Keohane P (1987) The 24-Hour Acid Suppression Profile of Nizatidine. Scand J Gastroenterol 22 (Suppl 136): 56

    Google Scholar 

  • Dammann HG, Dau B, Dreyer M, Müller P, Simon B (1987 a) H2-Rezeptoranta-gonisten in der Therapie der peptischen Ulkuserkrankung. Z Gastroenterol (Suppl 3): 136

    Google Scholar 

  • Demling L, Domschcke S (1984) Klinische Gastroenterologie, 2. Aufl. Thieme, Stuttgart

    Google Scholar 

  • Devis G (1987) Nizatidine in Duodenal Ulcer Disease — European Experience. European Nizatidine Symposium, Brussels

    Google Scholar 

  • Dicke JM, Johnson RF, Henderson BI, Kühl TJ, Schenker S (1988) A Comparative Evaluation of the Transport of H2-Receptor Antagonists by the Human and Baboon Placenta. Am J Med Sci 295(3): 198

    CAS  PubMed  Google Scholar 

  • DiMario F (1987) Ranitidine and Nizatidine Action on Peptic Secretion. Gastroenterology 92(5): 1371

    Google Scholar 

  • Duroux P (1987) Overnight Acid Suppression Profile of Nizatidine 300 mg Effect of 6.00 p.m. and 9.00 p.m. Dosing. European Nizatidine Symposium, Brussels

    Google Scholar 

  • Dyck W, Cloud M, Offen W, Matsumoto C, Chernish S (1987) Treatment of Duodenal Ulceration in the United States. Scand J Gastroenterol 22 (Suppl 136): 47

    Google Scholar 

  • Evans D, Ruffolo R, Warrick M, Lin T (1984) Specific Histamine (H-2)-Receptor Antagonist Actions of Nizatidine. Fed Proc 43(4): 1074

    Google Scholar 

  • Fordtran JS (1985) A Study of the Efficacy of Four Dosis of Nizatidine as Compared to Cimetidine and Placebo as an H2-Antagonist to Suppress Food-stimulated Gastric Acid Secretion in Volunteers. Lilly Research Labs. — Clinical Dokumentation Protocol 20 (unveröffentlichte Daten)

    Google Scholar 

  • Fullarton GM, McLanchlan G, MacDonald A, Crean GP, McColl KEL (1988) Rebound Noctural Hypersecretion after four Weeks H2-Antagonist therapy. Gut 29: A1439

    Google Scholar 

  • Ganellin C, Durant G, Emmett J et al. (1985) Recent Structure-Activity Studies of H2-Receptor Histamine Antagonists. Acta Pharm Suec 2 (Suppl): 153

    Google Scholar 

  • Gledhill T, Howard O, Buch M (1983) Single Nocturnal Dose of an H2-Receptor Antagonist for the Treatment of Duodenal Ulcer. Gut 24: 904

    CAS  PubMed Central  PubMed  Google Scholar 

  • Grasela T, Welage D, Adelman M (1987) Population Analysis of Nizatidine Concentration — Effect Data. Clin Pharmacol Ther 41 (Suppl 2): 167

    Google Scholar 

  • Greenblatt DJ, Aberneth D, Morse J (1985) Clinical Importance of the Interaction with Cimetidine. Pharmacol Ther 27: 353

    Google Scholar 

  • Hagopian GS (1984) A Teratology Study in Dutch Belted Rabbits Given Oral Doses of Nizatidine. Lilly Research Labs. — Toxicology Report Nr.30 (unveröffentlichte Daten)

    Google Scholar 

  • Hakason R et al. (1986) Gastric and Trophic Control of Gastric Mucosa. Scand J Gastroenterol 21 (Suppl 118): 18

    Google Scholar 

  • Hammond J, Offen W (1988) Effect of Nizatidine and Cimetidine on Betazole-Stimulated Gastric Secretion of Normal Subjects. Am J Gastroenterol 83(1): 32

    CAS  PubMed  Google Scholar 

  • Hanlin ML (1981) Anti-Androgenic Studies with Nizatidine in the Male Rat. Lilly Research Labs. — Pharmacology Report Nr.9 (unveröffentlichte Daten)

    Google Scholar 

  • Hentschel E, Schütze K, Dutch W (1984) Relaps Rates of Duodenal Ulcer Healed with Concentrated Antacid or Cimetidine. Hepatogastroenterology 31: 266

    CAS  PubMed  Google Scholar 

  • Hentschel E, Schütze K, Reichel W et al. (1987) Nizatidine Versus Ranitidine in the Prevention of Duodenal Ulcer Relapse. Scand J Gastroenterol 22 (Suppl 136): 84

    Google Scholar 

  • Hill LE (1981) The Effect of Nizatidine on the Induction of DNA Repair Synthesis in Primary Cultures of Adult Rat Hepatocytes. Lilly Research Labs. — Toxicology Report Nr. 14 (unveröffentlichte Daten)

    Google Scholar 

  • Hirsch KS (1985) Effect of Nizatidine, Cimetidine and Ranitidine of the Tissue Uptake and Nuclear Translocation of 3H-R1181 in the Male Rat. Lilly Research Labs. — Pharmacology Report Nr.12 (unveröffentlichte Daten)

    Google Scholar 

  • Holland DR, Turk JA, Bemis KG, Beckheim GA (1981) Cardiovascular and Respiratory Effects of Intravenous Administration of Nizatidine in Anesthetized Dogs. Lilly Research Labs. — Pharmacology Report Nr.6 (unveröffentlichte Daten)

    Google Scholar 

  • Kattau RW, Rathbun RC, Bemis KG (1981) Effects of Nizatidine in Mice. Lilly Research Labs. — Pharmacology Report Nr. 8 (unveröffentlichte Daten)

    Google Scholar 

  • Kirsch W, Ohnhaus E (1987) Neuere Aspekte zu Arzneimittelwechselwirkungen mit den H2-Antagonisten Cimetidine und Ranitidine. Med Klin 82: 400

    Google Scholar 

  • Klotz U, Dammann HG, Gottlieb W, Walter T, Keohane P (1987) Nizatidine (300 mg nocte) Does Not Interfere with Diazepam Pharmacokinetics in Man. Br J Clin Pharmacol 23:105

    CAS  PubMed Central  PubMed  Google Scholar 

  • Klotz U (1987 a) Lack of Effect of Nizatidine on Drug Metabolism. Scand J Gastroenterol 22 (Suppl 136): 18

    Google Scholar 

  • Klotz U, Gottlieb W, Keohane P, Dammann HG (1987 b) Nocturnal Doses of Ranitidine and Nizatidine Do Not Affect the Disposition of Diazepam. J Clin Pharmacol 27: 210

    CAS  PubMed  Google Scholar 

  • Klotz U (1987 c) Comparative Effects of H2-Receptor Antagonists on Drug Metabolism in vitro and in vivo. Pharmacol Ther 33:157

    CAS  PubMed  Google Scholar 

  • Knadler M, Rubin A, Bergstrom R, Callaghan J (1984) Effects of Gelusil, Charcoal and Propantheline on the Bioavailability of the H2-Blocker Nizatidine. Pharmacologist 26: 236

    Google Scholar 

  • Knadler M, Bergstrom R, Callaghan J, Rubin A (1986) Nizatidine, an H2-Blocker, Its Metabolism and Disposition in Man. Drug Metab Disp 14(2): 175

    CAS  Google Scholar 

  • Knadler M, Bergstrom R, Callaghan J, Obermeyer B, Rubin A (1987) Absorption Studies of the H2-Blocker Nizatidine. Clin Pharmacol Ther 43/5: 514

    Google Scholar 

  • Koop H, Arnold R (1987) Konsequenzen therapeutischer Langzeitachlorhydrie. Internist 28: 8

    CAS  PubMed  Google Scholar 

  • Kounenis G, Koutsoviti-Papadopoulou M, Elezoglou V (1987) The Excitatory Effect of the New Histamin H2-Receptor-Antagonist Nizatidine (LY 390037) on the Guinea Pig lleum. J Pharmacobiodyn 10: 669

    CAS  PubMed  Google Scholar 

  • Kovacs T, Maxwell V, Sytnik B, Van Deventer G, Walsh J (1986) The Effects of Three Oral Doses of Nizatidine and Placebo on Nocturnal and Peptone-Stimulated Gastric Acid Secretion. Western Sect Gastroenterol 34: 29

    Google Scholar 

  • Kovacs T, Van Deventer G, Maxwell V, Sytnik B, Walsh J (1986 a) The Effects of an Oral Evening Dose of Nizatidine on Nocturnal and Peptone-Stimulated Gastric Acid Secretion. Gastroenterology 90(5): 1502

    Google Scholar 

  • Kovacs T, Van Deventer G, Maxwell V, Sytnik B, Walsh J (1987) The Effect of an Oral Evening Dose of Nizatidine on Nocturnal and Peptone-Stimulated Gastric Acid. Scand J Gastroenterol 22 (Suppl 136): 41

    Google Scholar 

  • Langmann MJS (1985) Antisecretory Drugs and Gastric Cancer. Br Med J 290: 1850

    Google Scholar 

  • Lanzon-Miller S, Pounder RE, Chronos N, Raymond F, Hamilton MR, Dalgleish D (1988) Twenty-four Hour Intragastric Acidity and Plasma Gastrin Concentration in Healthy Volunteers taking Nizatidine 150 mg, Nizatidine 300 mg, Ranitidine 300 mg, or Placebo at 2100 h. Gut 29:1364

    CAS  PubMed Central  PubMed  Google Scholar 

  • Lasseier K (1986) Nizatidine Pharmacokinetics in Hepatic Disease. Lilly Research Labs. — Clinical Dokumentation Protocol 37 (unveröffentlichte Daten)

    Google Scholar 

  • Leslie G, Walter T (1977) A Toxicology Profile of Cimetidine. In: Burland W, Sim-kins M (eds) Cimetidine. Excerpta Medica, Amsterdam, p 24

    Google Scholar 

  • Levendoglu H, Mehta B, Wait C, Reddy G, Hatcher C (1986) Nizatidine: A New Histamine Receptor Blocker in the Treatment of Active Duodenal Ulcers. Am J Gastroenterol 81(12): 1167

    CAS  PubMed  Google Scholar 

  • Levendoglu H, Mehta B, Wait C, Reddy G, Hatcher C (1986 a) Effect of Nizatidine on Duodenal Ulcer Healing. IRCS Med Sci 14: 345

    Google Scholar 

  • Lin T, Evans DC (1981) Gastrointestinal Actions of LY13907. Lilly Research Labs. — Pharmacology Report Nr. 1 (unveröffentlichte Daten)

    Google Scholar 

  • Lin T (1981 a) Pharmacological Evaluation of Nizatidine in Isolated Smooth and Cardiac Muscle Preparations. Lilly Research Labs. — Pharmacology Report Nr. 5 (unveröffentlichte Daten)

    Google Scholar 

  • Lin T, Evans D, Warrick M, Pioch R, Ruffolo R (1983) Nizatidine, A New Specific H2-Receptor Antagonist. Gastroenterology 84:1231

    Google Scholar 

  • Lin T, Evans DC (1984) Effect of Nizatidine on Gastric Acid Secretion Induced by Methacholin HCL. Lilly Research Labs. — Pharmacology Report Nr.3 (unveröffentlichte Daten)

    Google Scholar 

  • Lin T (1985) Absorption of Nizatidine in Different Segments of the Gastrointestinal Tract. Lilly Research Labs. — Pharmacology Report Nr. 19 (unveröffentlichte Daten)

    Google Scholar 

  • Lin T, Evans D, Warrick M, Ruffolo R (1986) Actions of Nizatidine on the Rat Uterus, Dog Stomach and Experimentally Induced Gastric Lesions. J Pharmacol Exp Ther 239(2): 400

    CAS  PubMed  Google Scholar 

  • Lin T, Evans D, Warrick M, Pioch R (1986 a) Actions of Nizatidine, A Selective Histamine H2-Receptor Antagonist, on Gastric Acid Secretion in Dogs, Rats and Frogs. J Pharmacol Exp Ther 239(2): 406

    CAS  PubMed  Google Scholar 

  • Lindstrom TD, Whitaker G (1985) Effect of Ranitidine, Cimetidine and Nizatidine (LY139037) upon Cytochrome P450 Content in Male Rats and upon Ethylmorphine N-Demethylation in vitro. Lilly Research Labs. — Pharmacology Report Nr.14 (unveröffentlichte Daten)

    Google Scholar 

  • Lindstrom TD, Whitaker G (1985 a) The Effect of Nizatidine Upon Hepatic Weight, Microsomal Protein and Microsomal Cytochrome P450 in Mice. Lilly Research Labs. — Pharmacology Report Nr.15 (unveröffentlichte Daten)

    Google Scholar 

  • Linscheer W, Raheja K, Hirose N (1985) A Double Blind Controlled Study Proves Nizatidine to be Much More Potent than Cimetidine. Gastroenterology 88 (5, Part 2): 1478

    Google Scholar 

  • Lucas RA, Keohane PP (1986) Evaluation of the Pharmaceutics of Nizatidine in Elderly Subjects. Lilly Research Labs. — Clinical Dokumentation Protocol B5Q-17 (unveröffentlichte Daten)

    Google Scholar 

  • Magee D (1974) Pepsin. Med Clin North Am 58(6): 1277

    CAS  PubMed  Google Scholar 

  • Meredith C, Speeg K, Schenker S (1983) The Effect of Nizatidine (A New H2-Receptor Antagonist) on Hepatic Oxidative Drug Metabolism in the Rat. Clin Res 31: 765A

    Google Scholar 

  • Meredith C, Speeg K, Schenker S (1985) Nizatidine, A New Histamine H2-Receptor Antagonist, and Hepatic Oxidative Drug Metabolism. Toxicol Appl Pharmacol 77: 315

    CAS  PubMed  Google Scholar 

  • Miller BJ (1983) A Basic Fertility Study in Wistar Rats given Nizatidine in the Diet. Lilly Research Labs. — Toxicology Report Nr. 25 (unveröffentlichte Daten)

    Google Scholar 

  • Miller BJ (1983 a) A Basic Fertility Study in Fischer 344 Rats Given Nizatidine in the Diet. Lilly Research Labs. — Toxicology Report Nr.24 (unveröffentlichte Daten)

    Google Scholar 

  • Miller BJ (1985) A Fertility, Perinatal and Postnatal Study in Wistar Rats given Diets on Containing Nizatidine. Lilly Research Labs. — Toxicology Report Nr. 39 (unveröffentlichte Daten)

    Google Scholar 

  • Miller L (1987) 24-hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking Nizatidine 150, 300, Ranitidine 300 oder placebo at 21.15. Gastroenterology 92 (5, Part 2): 1492

    Google Scholar 

  • Missale G, Agosti A, Bertele A (1987) Inhibition of gastric acid secretion in man by nizatidine and ranitidine. Ital J Gastroenterol 19(5): 261

    CAS  Google Scholar 

  • Mitchell M (1987) Nizatidine Maintenance Therapy in Duodenal Ulcer Disease-European Experience. European Nizatidine Symposium, Brussels

    Google Scholar 

  • Morton D (1987) Pharmacology and Toxicology of Nizatidine. Scand J Gastroenterol 22 (Suppl 136): 1

    Google Scholar 

  • Müller P, Dammann HG, Simon B (1985) Gezielte Hemmung der nächtlichen Säuresekretion. MMW 127(43): 1019

    Google Scholar 

  • Naccaratto R, Cremer M, Dammann HG et al. (1987) Nizatidine Versus Raniti-dine in Gastric Ulcer Disease. Scand J Gastroenterol 22 (Suppl 136): 71

    Google Scholar 

  • Neal SG (1982) The Effect of LY139037 on the In Vivo Induction of Sister Chromatic Exchange in Bone Marrow of Chinese Hamsters. Lilly Research Labs. — Toxicology Report Nr.20 (unveröffentlichte Daten)

    Google Scholar 

  • Neal SG (1982 a) The Effect of Nizatidine in the In Vivo Induction of Sister Chromatid Exchange in Bone Marrow of Chinese Hamsters. Lilly Research Labs. — Toxicology Report Nr.21 (unveröffentlichte Daten)

    Google Scholar 

  • Neubauer BL (1984) Endocrine Studies with Nizatidine, Cimetidine and Ranitidine HC1 in the Male Rat. Lilly Research Labs. — Pharmacology Report Nr.11 (unveröffentlichte Daten)

    Google Scholar 

  • Newman KS (1981) A Subchronic Toxicity Study of Nizatidine Given in Daily Intraveneous Doses to Fischer 344 Rats for 1 Month. Lilly Research Labs. — Toxicology Report Nr.9 (unveröffentlichte Daten)

    Google Scholar 

  • Newman KS (1981 a) The Acute Intravenous Toxicity of Nizatidine in Dogs. Lilly Research Labs. — Toxicology Report Nr. 5 (unveröffentlichte Daten)

    Google Scholar 

  • Newman KS (1981 b) The Acute Intramuscular Toxicity of Nizatidine in Dogs. Lilly Research Labs. — Toxicology Report Nr.7 (unveröffentlichte Daten)

    Google Scholar 

  • Newman KS (1981 c) The Acute Intraveneous Toxicity of Nizatidine in Monkeys. Lilly Research Labs. — Toxicology Report Nr.6 (unveröffentlichte Daten)

    Google Scholar 

  • Newman KS (1981 d) The Subchronic Toxicity of Nizatidine Given in Daily Intravenous Doses to Dogs for 1 Month. Lilly Research Labs. — Toxicology Report Nr.11 (unveröffentlichte Daten)

    Google Scholar 

  • Newman KS (1983) A Subchronic Toxicity Study of Nizatidine Given in the Diet to Fischer 344 Rats for 3 Months. Lilly Research Labs. — Toxicology Report Nr.22 (unveröffentlichte Daten)

    Google Scholar 

  • Newman KS (1983 a) A Subchronic Toxicity Study of Nizatidine in Beagle Dogs Receiving Daily Oral Doses of Nizatidine for Three Months. Lilly Research Labs. — Toxicology Report Nr.23 (unveröffentlichte Daten)

    Google Scholar 

  • Newman KS (1983 b) A Comparison of Nizatidine with Cimetidine for Inhibition of Aromatose Activity. Lilly Research Labs. — Toxicology Report Nr.28 (unveröffentlichte Daten)

    Google Scholar 

  • Offen W, Matsumoto C, Cloud M (1986) Efficacy of 8 Weeks of Nizatidine Therapy in the Treatment of Acute Duodenal Ulcer. Am J Gastroenterol 81(9): 867

    Google Scholar 

  • Offen W, Matsumoto C, Cloud M (1986 a) The Effectiveness of 4 to 8 Weeks of Nizatidine 150 mg Twice Daily in the Treatment of Active Duodenal Ulcer Disease. Am J Gastroenterol 81(9): 867

    Google Scholar 

  • Pace F, Colombo E, Ferrara A, Prada A, Rocca F, Bianchi Porro G (1988) Treatment of Duodenal Ulcer. A Cooperative Double-Blind Study of Once-DailyBedtime Administration. Am J Gastroenterol 83(6): 643

    CAS  PubMed  Google Scholar 

  • Pasanen M, Arvela P, Pelkonen O, Sotaniemi E, Klotz U (1986) Effect of 5 Structurally Diverse H2-Receptor Antagonists on Drug Metabolism. Biochem Pharmacol 35(34): 4457

    CAS  PubMed  Google Scholar 

  • Penston J, Wormsley KG (1987) Achlorhydria: Hypergastrinaemia: Carcinoids — a Flawed Hypothesis? Gut 28: 488

    CAS  PubMed Central  PubMed  Google Scholar 

  • Pippenger CE (1982) Drug Protein Binding. An Overview. In: Moyer T, Boeckx R (eds) Applied Therapeutic Drug Monitoring Fundamentals, Vol 1. Am Ass for Clinical Chemistry, Washington DC, p 55

    Google Scholar 

  • Porro GB (1985) Efficacy and Safety of Acid Suppression by Oral Nizatidine in Volunteer Subjects. Lilly Research Labs. — Clinical Dokumentation Protocol B5Q-13 (unveröffentlichte Daten)

    Google Scholar 

  • Porro GB (1987) Nizatidine in the Treatment of Gastric Ulcer Disease. European Nizatidine Symposium, Brussels

    Google Scholar 

  • Poynter D et al. (1981) The Clinical Use of Ranitidine. Proc. 2. Int Symp on Ranitidine, Medicine Publishing Foundation, Oxford

    Google Scholar 

  • Probst KS (1984) A Subchronic Toxicity Study of Nizatidine Given in the Diet to B6C3F1 Mice for 3 Months. Lilly Research Labs. — Toxicology Report Nr.36 (unveröffentlichte Daten)

    Google Scholar 

  • Probst KS (1984 a) A Chronic Toxicity Study of Nizatidine Given in the Diet to Fischer 344 Rats for Six Months. Lilly Research Labs. — Toxicology Report Nr.34 (unveröffentlichte Daten)

    Google Scholar 

  • Probst KS (1985) Placental Transfer and Milk Excretion of Radiocarbon Following the Administration of a Single Oral Dose of 14C Nizatidine to Fendle Rats. Lilly Research Labs. — Toxicology Report Nr.40 (unveröffentlichte Daten)

    Google Scholar 

  • Probst KS, Bernhard NR (1985 a) A Chronic Toxicity Study in Beagle Dogs Given Daily Oral Doses of Nizatidine for One Year. Lilly Research Labs. — Toxicology Report Nr.38 (unveröffentlichte Daten)

    Google Scholar 

  • Probst KS (1985 b) A Chronic Toxicity Study of Nizatidine Given in the Diet to Fischer 344 Rats for One Year. Lilly Research Labs. — Toxicology Report Nr.37 (unveröffentlichte Daten)

    Google Scholar 

  • Probst KS (1985 c) A Chronic Toxicity/Oncogenicity Study of Nizatidine Given in the Diet to B6C3F1 Mice for Two Years. Lilly Research Labs. — Toxicology Report Nr.41 (unveröffentlichte Daten)

    Google Scholar 

  • Probst KS (1986) The Effects of Nizatidine (LY139037) on the Hepatic Microsomal Enzyme Activity. Lilly Research Labs. — Toxicology Report Nr.47 (unveröffentlichte Daten)

    Google Scholar 

  • Probst KS (1986 a) A Chronic Toxicity/Oncogenicity Study in Fischer 344 Rats Given Nizatidine in the Diet for Two Years. Lilly Research Labs. — Toxicology Report Nr.46 (unveröffentlichte Daten)

    Google Scholar 

  • Probst KS (1986 b) The Effect of Nizatidine on the Induction of Chromosome Aberrations in Cultured CHO Cells. Lilly Research Labs. — Toxicology Report Nr. 52 (unveröffentlichte Daten)

    Google Scholar 

  • Quarles JP (1981) The Acute Subcutaneous Toxicity of Nizatidine in ICR Mice. Lilly Research Labs. — Toxicology Report Nr.15 (unveröffentlichte Daten)

    Google Scholar 

  • Quarles JP (1981 a) The Acute Subcutaneous Toxicity of Nizatidine in Fischer 344 Rats. Lilly Research Labs. — Toxicology Report Nr.16 (unveröffentlichte Daten)

    Google Scholar 

  • Rainen D, Curik M, Rodvold K, Deyo K, Scaros L, Fischer J (1988) Stability of Nizatidine in Commonly used Intraveneous Fluids and Containers. Am J Hosp Pharmacol 45:1523

    Google Scholar 

  • Reichel W, Brandstätter G, Hentschel E et al. (1987) Nizatidine vs. Ranitidine in der Therapie des Ulcus duodeni. Z Gastroenterol 25(8): 545

    Google Scholar 

  • Rexroat MA (1984) The Effect of Nizatidine on the Induction of Reverse Mutations in Salmonella typhimurium Using the Ames Test. Lilly Research Labs. — Toxicology Report Nr. 32 (unveröffentlichte Daten)

    Google Scholar 

  • Roberts NB, Sheers R, Taylor W (1981) Pepsin 1 Secretion in Normal Human Subjects. Clin Sci 61: 37

    Google Scholar 

  • Roberts CJC (1984) Clinical Pharmacokinetics of Ranitidine. Clin Pharmakokinet 9:211

    CAS  Google Scholar 

  • Roberts R, Heath C, Johnson R, Speeg K, Schenker S (1986) Effect of H2-receptor Antagonists on Steady-State Extraction of Indocyanine Green and Lidocaine. J Lab Clin Med 107(2): 112

    CAS  PubMed  Google Scholar 

  • Ryan J (1985) The Effect of Three Oral Doses of Nizatidine and Placebo on Nocturnal and Food stimulated Gastric Acid Secretion. Lilly Research Labs. — Clinical Dokumentation Protocol 32 (unveröffentlichte Daten)

    Google Scholar 

  • Ryan J, Vargas R, McMahon F, Gotzkowsky S, Matsumoto C (1986) Dose-Response Efficacy of Intraveneous Nizatidine on Gastric Secretion and Acidity. Am J Gastroenterol 81(9): 857

    Google Scholar 

  • Samanta A, Nahass D, Habba S (1986) Efficacy of Nizatidine: A New H2-Receptor Antagonist in the Treatment of Duodenal Ulcer: A Dose Response Study. Am J Gastroenterol 81(9): 852

    Google Scholar 

  • Schenker S, Johnson R, Mor L, Henderson G, Dicke J (1986) Human Placental Transport of Cimetidine, Ranitidine and Nizatidine. Clin Res 34(2): 445A

    Google Scholar 

  • Secor J, Speeg K Meredith C, Johnson R, Snowdy P, Schenker S (1985) Lack of Effect of Nizatidine on Hepatic Drug Metabolism in Man. Br J Clin Pharmacol 20: 710

    CAS  PubMed Central  PubMed  Google Scholar 

  • Sever P (1984) Efficacy and Safety of Acid Suppression by Oral Nizatidine LY 139037 in Volunteer Subjects. Lilly Research Labs. — Clinical Dokumentation Protocol 31 (unveröffentlichte Daten)

    Google Scholar 

  • Shaar CJ (1982) Effect of Nizatidine and Cimetidine on Plasma Prolactin Concentration in Male Rats. Lilly Research Labs. — Pharmacology Report Nr.10 (unveröffentlichte Daten)

    Google Scholar 

  • Simon B (1986) Beschleunigte Ulkus Duodeni-Abheilung unter 300 mg Nizatidine nocte. Z Gastroenterologie 24(9): 465

    Google Scholar 

  • Simon B (1986 a) Nocturnal Nizatidine Accelerates Duodenal Ulcer Healing. Dig Dis Sci 31,10 (Suppl): Abstract 1926

    Google Scholar 

  • Simon B, Cremer M, Dammann HG et al. (1987) 300 mg Nizatidine at Night Versus 300 mg Ranitidine at Night in Patients with Duodenal Ulcer. Scand J Gastroenterol 22 (Suppl 136): 61

    Google Scholar 

  • Soll AN (1978) The Action of Secretagogues on Oxygen Uptake by Isolated Mammalian Parietal Cells. J Clin Invest 61: 371

    Google Scholar 

  • Somogyi A (1983) Clinical Pharmacokinetics of Cimetidine. Clin Pharmacokinet 8:463

    CAS  PubMed  Google Scholar 

  • Spahn H (1989) Lack of Significant Effect of Nizatidine and Ranitidine on the Plasma Concentrations of Metoprolol Enatiomers. Submitted: Br J Clin Pharmacol

    Google Scholar 

  • Streett CS et al. (1984) Pathologic Findings in the Stomachs of Rats Treated with the H2-Receptor Antagonist Tiotidine. Scand J Gastroenterol 19 (Suppl 101): 109

    CAS  Google Scholar 

  • Stone RL (1981) Test of Compound Nizatidine for Effects of the Immune Response in Mice. Lilly Research Labs. — Pharmacology Report Nr.13 (unveröffentlichte Daten)

    Google Scholar 

  • Sullivan HR (1981) Preclinical Pharmakokinetics and Metabolism Studies. Lilly Research Labs. — Pharmacology Report Nr.15 (unveröffentlichte Daten)

    Google Scholar 

  • Sullivan HR (1982) Preclinical Pharmacokinetics and Metabolism Studies. Lilly Research Labs. — Pharmacology Report Nr. 16 (unveröffentlichte Daten)

    Google Scholar 

  • Sullivan HR (1984) Preclinical Pharmacokinetics and Metabolism Studies. Lilly Research Labs. — Pharmacology Report Nr.17 (unveröffentlichte Daten)

    Google Scholar 

  • Sundler F et al. (1986) Inhibition of Gastric Acid Secretion by Omeprazole and Ranitidine. Scand J Gastroenterol 21 (Suppl 118): 38

    Google Scholar 

  • Thiel van D, Gavaler J, Heyl A, Susen B (1987) An Evaluation of the AntiAndrogen Effects Associated with H2-Antagonist Therapy. Scand J Gastroenterol 22 (Suppl 136): 24

    Google Scholar 

  • Thompson CZ (1980) The Effect of Nizatidine on the Induction of Bacterial Mutation Using a Modification of the Ames Test. Lilly Research Labs. — Toxicology Report Nr.13 (unveröffentlichte Daten)

    Google Scholar 

  • Turner JC, Sullivan HR (1986) Nizatidine Preclinical Pharmacokinetics and Metabolic Transformation Studies. Lilly Research Labs. — Pharmacology Report Nr.20 (unveröffentlichte Daten)

    Google Scholar 

  • Vargas R, Ryan J, McMahon F, Regel C (1985) The Comparative Efficacy of Nizatidine to Cimetidine in Gastric Hypersecretors. J Clin Pharmacol 25(6): 455

    Google Scholar 

  • Vargas R, Ryan J, McMahon G, Regel C, Offen W, Matsumoto C (1988) Pharmacokinetics and Pharmacodynamics of Oral Nizatidine. J Clin Pharmacol 28: 71

    CAS  PubMed  Google Scholar 

  • Venables C (1986) Mucus, Pepsin, and Peptic Ulcer. Gut 27: 233

    CAS  PubMed Central  PubMed  Google Scholar 

  • Warrick MW, Lin TM (1976) Actions of Somatostatine and Metiamide on Gastric Acid Secretion from Isolated Bullfrog Gastric Mucosa. Res Commun Chem Pathol Pharmacol 13:149

    CAS  PubMed  Google Scholar 

  • Welage L, Wing P, Thomas R, Mueller G, Bernhard H, Schentag J (1986) The Effect of Intraveneous Nizatidine on Stimulated Gastric Acid Secretion. J Clin Pharmacol 26: 559

    Google Scholar 

  • Welage L, Grasela T, Thomas R, Wing P, Mueller G (1987) The Concentration Effect Relationship of Nizatidine on Stimulated Gastric Acid Secretion. Clin Pharmacol Ther 41(2): 225

    Google Scholar 

  • White JF (1981) A 14-Day Acute Toxicity Study of LY139037 Administered Orally to Beagle Dogs. Lilly Research Labs. — Toxicology Report Nr.17 (unveröffentlichte Daten)

    Google Scholar 

  • Winters SJ, Banks JL, Loriaux DL (1979) Cimetidine is an Anti-Androgen in the Rat. Gastroenterology 76: 504

    CAS  PubMed  Google Scholar 

  • Wormsley KG (1982) Ranitidin in der Rezidivprophylaxe der peptischen Ulkuserkrankung. Gastroenterolog Prax Suppl II: 19

    Google Scholar 

  • You C, Lee S, Chey W (1985) The Effect of New H2-Blocker (Nizatidine) on Gastric Acid Secretion: Comparison with Cimetidine. Gastroenterology 88:1639

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Zentrum Innere Medizin, Abteilung für Gastroentrologie, Klinikum der Philipps-Universität, Baldingerstraße, D-3550, Marburg/Lahn, Deutschland

    Professor Dr. med. Rudolf Arnold

  2. Krankenhaus Bethanien, Martinistraße 44-46, D-2000, Hamburg 20, Deutschland

    Professor Dr. med. Hanns-Gerd Dammann

  3. Schwerpunktkrankenhaus Elmshorn, Agnes-Karll-Allee, D-2200, Elmshorn, Deutschland

    Dr. med. Peter Minartz

  4. Auf der Steige 11, D-5300, Bonn-Kessenich 1, Deutschland

    Professor Dr. med. Hans-Dieter Peters

  5. Krankenhaus Schwetzingen, Bodelschwingh Straße 11, D-6830, Schwetzingen, Deutschland

    Professor Dr. Bernd Simon

Authors
  1. Professor Dr. med. Rudolf Arnold
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Professor Dr. med. Hanns-Gerd Dammann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dr. med. Peter Minartz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Professor Dr. med. Hans-Dieter Peters
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Professor Dr. Bernd Simon
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Zentrum Innere Medizin, Abteilung für Gastroentrologie, Klinikum der Philipps-Universität, Baldingerstraße, D-3550, Marburg/Lahn, Deutschland

    Rudolf Arnold

  2. Krankenhaus Bethanien, Martinistraße 44-46, D-2000, Hamburg 20, Deutschland

    Hanns-Gerd Dammann

  3. Schwerpunktkrankenhaus Elmshorn, Agnes-Karll-Allee, D-2200, Elmshorn, Deutschland

    Peter Minartz

  4. Auf der Steige 11, D-5300, Bonn-Kessenich 1, Deutschland

    Hans-Dieter Peters

  5. Krankenhaus Schwetzingen, Bodelschwingh Straße 11, D-6830, Schwetzingen, Deutschland

    Bernd Simon

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Arnold, R., Dammann, HG., Minartz, P., Peters, HD., Simon, B. (1989). Literatur. In: Arnold, R., Dammann, HG., Minartz, P., Peters, HD., Simon, B. (eds) Nizatidin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74410-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-74410-5_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-74411-2

  • Online ISBN: 978-3-642-74410-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation